These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18567738)

  • 1. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.
    Smith EL; Schuchman EH
    FASEB J; 2008 Oct; 22(10):3419-31. PubMed ID: 18567738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
    Schuchman EH
    FEBS Lett; 2010 May; 584(9):1895-900. PubMed ID: 19944693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase--deficient mouse model of Niemann-Pick disease.
    Dhami R; He X; Gordon RE; Schuchman EH
    Lab Invest; 2001 Jul; 81(7):987-99. PubMed ID: 11454988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
    Suchi M; Dinur T; Desnick RJ; Gatt S; Pereira L; Gilboa E; Schuchman EH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3227-31. PubMed ID: 1565614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
    Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.
    Horinouchi K; Erlich S; Perl DP; Ferlinz K; Bisgaier CL; Sandhoff K; Desnick RJ; Stewart CL; Schuchman EH
    Nat Genet; 1995 Jul; 10(3):288-93. PubMed ID: 7670466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease.
    Ziegler RJ; Brown C; Barbon CM; D'Angona AM; Schuchman EH; Andrews L; Thurberg BL; McPherson JM; Karey KP; Cheng SH
    Mol Genet Metab; 2009 May; 97(1):35-42. PubMed ID: 19231265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.
    Jones I; He X; Katouzian F; Darroch PI; Schuchman EH
    Mol Genet Metab; 2008 Nov; 95(3):152-62. PubMed ID: 18815062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.
    Ikegami M; Dhami R; Schuchman EH
    Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L518-25. PubMed ID: 12495943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
    He X; Chen F; Gatt S; Schuchman EH
    Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.
    Jin HK; Carter JE; Huntley GW; Schuchman EH
    J Clin Invest; 2002 May; 109(9):1183-91. PubMed ID: 11994407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms.
    Takahashi T; Suchi M; Desnick RJ; Takada G; Schuchman EH
    J Biol Chem; 1992 Jun; 267(18):12552-8. PubMed ID: 1618760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of acid sphingomyelinase for cancer therapy.
    Savić R; Schuchman EH
    Adv Cancer Res; 2013; 117():91-115. PubMed ID: 23290778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
    Schuchman EH
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S48-57. PubMed ID: 20040312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice.
    Taha AY; Gaudioso Á; Moran-Garrido M; Camunas-Alberca SM; Bachiller-Hernández J; Sáiz J; Ledesma MD; Barbas C
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110896. PubMed ID: 37956788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
    Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH
    Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction.
    Yeyati PL; Agmon V; Fillat C; Dinur T; Dagan A; Desnick RJ; Gatt S; Schuchman EH
    Hum Gene Ther; 1995 Aug; 6(8):975-83. PubMed ID: 7578419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
    Graber D; Salvayre R; Levade T
    J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and expression of a missense mutation (Y446C) in the acid sphingomyelinase gene from a Japanese patient with type A Niemann-Pick disease.
    Takahashi T; Suchi M; Sato W; Ten SB; Sakuragawa N; Desnick RJ; Schuchman EH; Takada G
    Tohoku J Exp Med; 1995 Oct; 177(2):117-23. PubMed ID: 8693491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and noncorrected NPD fibroblasts using a novel fluorescent sphingomyelin.
    Dinur T; Schuchman EH; Fibach E; Dagan A; Suchi M; Desnick RJ; Gatt S
    Hum Gene Ther; 1992 Dec; 3(6):633-9. PubMed ID: 1482703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.